BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Genetown

  Cambridge Startup Inozyme Nabs $49M and a Roster Packed With Seasoned Vets

  The $49M in Series A funding will be used to develop the company’s enzyme replacement therapies for two rare diseases affecting infants and children and push the treatments into the clinic.

  November 15, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Drug Development

  5 Deaths Force Acorda to Stop Enrollment in Phase III Parkinson’s Trial

  Acorda Therapeutics updated its Phase III clinical trial of tozadenant for Parkinson’s disease.

  November 15, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Business

  Genentech Dumps Another $650M in New Haven Biotech Arvinas

  Arvinas expanded an ongoing licensing deal with Genentech.

  November 15, 2017

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  With Merck Footing the $200M Bill, Moderna Launches mRNA Cancer Vaccine Clinical Trial

  Moderna announced that it has dosed its first patient in a Phase I trial of mRNA-4157, a mRNA-based personalized cancer vaccine.

  November 15, 2017

   · 

  3 min read

   · 

  Mark Terry
• Cygnus Raises $19.6M for Highly Accurate Sequencing Technology

  The financing was led by Zhonguancun Development Group and Shanghai Creation Investment Management.

  November 15, 2017

   · 

  1 min read
• 

  BioCapital

  MedImmune Exec Shares 4 Life Science Career Tips

  Jane Osbourn, VP of R&D for Biosuperiors at MedImmune shares some key career tips for life science employees.

  November 15, 2017

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Sangamo Scores Bragging Rights for First-in-Human Gene Editing Trial

  Barely a week after announcing it was moving into a new corporate headquarters, Sangamo announced it has dosed the first patient in its Phase I/II gene therapy trial.

  November 15, 2017

   · 

  2 min read

   · 

  Alex Keown
• 

  Job Trends

  Verily Ranked #1 for Interesting & Meaningful Work and Competitive Salary

  The opportunity to work at the leading edge of science and technology while working on solutions to some of the world’s most vexing problems is what attracts people to Verily.

  November 15, 2017

   · 

  3 min read

   · 

  Jennifer Fink
• 

  Business

  Meet the 5 Bay Area Biotech Entrepreneurs Under 30

  Every year, Forbes creates lists of “30 Under 30" leaders in various industries who are under the age of 30.

  November 15, 2017

   · 

  2 min read

   · 

  Mark Terry
• 

  Policy

  Florida’s RTI Surgical Discloses FDA Warning Letter Over Map3 Allograft Classification

  The company said it received the letter on November 9 based on an inspection of its facilities from April and that it is preparing an appropriate response to the letter.

  November 15, 2017

   · 

  1 min read